Author's Keywords: European Union, Biotechnology, Governance, Science Policy, Public Understanding of Science	Convention All Academic Convention can solve the abstract management needs for any association's annual meeting. Submission - Custom fields, multiple submission types, tracks, audio visual, multiple upload formats, automatic conversion to pdf. Review - Peer Review, Bulk reviewer assignment, bulk emails, ranking, z-score statistics, and multiple worksheets! Reports - Many standard and custom reports generated while you wait. Print programs with participant indexes, event grids, and more! Scheduling - Flexible and convenient grid scheduling within rooms and buildings. Conflict checking and advanced filtering. Communication - Bulk email tools to help your administrators send reminders and responses. Use form letters, a message center, and much more! Management - Search tools, duplicate people management, editing tools, submission transfers, many tools to manage a variety of conference management headaches! Click here for more information.
Association: Name: American Political Science Association URL: http://www.apsanet.org
Citation: URL: http://www.allacademic.com/meta/p208890_index.html Direct Link: HTML Code:

Fletcher, Amy. and Allen, Christopher. "BioBricks or BioConflicts? Building Public Trust in European Governance of Synthetic Biology" Paper presented at the annual meeting of the American Political Science Association, Hyatt Regency Chicago and the Sheraton Chicago Hotel and Towers, Chicago, IL, Aug 30, 2007 <Not Available>. 2011-06-08 <http://www.allacademic.com/meta/p208890_index.html>

Fletcher, A. L. and Allen, C. S. , 2007-08-30 "BioBricks or BioConflicts? Building Public Trust in European Governance of Synthetic Biology" Paper presented at the annual meeting of the American Political Science Association, Hyatt Regency Chicago and the Sheraton Chicago Hotel and Towers, Chicago, IL Online <APPLICATION/PDF>. 2011-06-08 from http://www.allacademic.com/meta/p208890_index.html

Publication Type: Conference Paper/Unpublished Manuscript Abstract: Is synthetic biology amenable to existing European governance structures? Synthetic biology is an emerging scientific field that seeks to make it easier for scientists to design and build de novo organisms. Crucial to its realization as an economic sector is the development of standardized and interchangeable biological units known as bio-bricks. Synthetic biology will have crucial applications in such areas as alternative fuels and energy security, environmental clean-up, and human health, and the European Union intends to prioritize consideration of the economic, technological and social implications of this highly complex, interdisciplinary field. However, the science raises significant governance issues with respect to public mistrust of techno-science, its potential use in new forms of biological terrorism and warfare, and the risk of environmental contamination by novel and self-replicating organisms that escape the laboratory. The multiple and interlocking complexities of synthetic biology make it an ideal case within which to analyze the development of regulatory frameworks for 21st century science, technology and innovation in the European Union (EU). This initial assessment focuses on the EU’s attempt to manage the tension between promoting the scientific/economic potential of synthetic biology, while responding effectively to stakeholder mistrust of and opposition to a scientific field that intends to build new biological systems. We argue that synthetic biology is a crucial test case of emerging European meta-governance. The EU seeks to encourage greater risk-taking and experimentation within the scientific and economic arenas, while simultaneously opening up conflicts over the bio-security and societal implications of synthetic biology to multiple stakeholders, civil society, and lay citizens. The ability of the European Union to coordinate these tensions, actors and governance levels in the absence of top down directives and management from the center will largely determine the pathway of not only synthetic biology, but also the related technologies (such as nanotechnology and neurotechnology) that will confront the most advanced societies of the 21st century.

Public Value Mapping: Developing a Non-Economic Model of the Social Value of Science and Innovation Policy

Culture Wars Over the Risks, Regulations, and Responsibilities in Genetic Agriculture: A Comparison of Food Biotechnology Policy in the United States and the European Union.

Biotechnology Governance and Risk Regulation in the European Union

Towards the emergence of a Europeanized public Sphere within the structures of policy making processes at EU level – considerations from a political science perspective